AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
Get a Sample Copy of this Report: https://www.alliedmarketresearch.com/request-sample/860
Market Growth Drivers
Rising Air Pollution & Urbanization: Increasing pollution and allergen exposure in urban areas have led to a spike in allergic conditions like asthma, rhinitis, and skin sensitivity.
Growing Food Allergies: Food-related allergies, especially in urban and developed regions, have created a consistent demand for accurate diagnostic tools.
Climate Change: Shifts in temperature and air quality are contributing to higher instances of skin and respiratory allergies.
Lifestyle Factors: Use of synthetic skincare products and changing dietary habits have exacerbated allergic responses in populations worldwide.
Emerging Diagnostic Technologies
In Vivo Testing: Includes skin prick, intradermal, and patch tests. These remain widely adopted due to their cost-effectiveness and reliability.
In Vitro Testing: Uses blood-based detection of allergen-specific immunoglobulin E (IgE). It’s expected to grow rapidly due to higher accuracy and compatibility with skin conditions.
Smart mHealth Tools: Smartphone-integrated biosensors, apps like MASK-Air, and wireless diagnostic tools are enhancing patient monitoring and remote diagnostics.
Key Market Insights
Consumables Segment Leads: Due to high testing volumes and increased allergy prevalence, consumables such as test kits and reagents dominate the product segment.
Inhaled Allergens Dominate: Allergies caused by pollen, dust, and mold are the most diagnosed, making inhaled allergens the largest allergen segment.
Diagnostic Labs at the Forefront: Independent and hospital-based labs are leading end-users, supported by technological investments and patient preference for accurate results.
High-Cost Barrier
Costly Equipment: Devices like luminometers ($3,000–$14,000) and immunoassay analyzers ($10,000–$20,000) remain unaffordable for small clinics and independent practitioners.
Operational Costs: Equipment maintenance, insurance, and infrastructure costs further limit adoption among low-resource facilities.
Regional Outlook
North America Leads: Driven by high allergy prevalence, awareness, healthcare infrastructure, and early adoption of advanced diagnostics.
Asia-Pacific Shows Fastest Growth: Increased pollution, western lifestyle adoption, and improving healthcare access contribute to the region’s rising market share.
Government Campaigns: Public health campaigns targeting food and drug allergy awareness are boosting diagnostic rates globally.
Major Players in the Market
Thermo Fisher Scientific
PerkinElmer Inc.
Danaher Corporation
bioMérieux
Hitachi Chemicals
Eurofins Scientific
Siemens Healthineers
Neogen Corporation
Stallergenes Greer
Omega Diagnostics Group PLC
Future Outlook
The allergy diagnostics market is expected to see technological integration, rising mHealth usage, and personalized allergy profiling as the future cornerstones. Strategic partnerships, AI-based diagnostic algorithms, and data-driven allergy management will further revolutionize this market in the coming years.
Key Takeaways
Global market to hit $16.7 billion by 2031.
In vivo testing and consumables dominate current market share.
Mobile health (mHealth) and point-of-care diagnostics are on the rise.
North America leads, but Asia-Pacific shows the fastest CAGR.
Accessibility and affordability challenges persist in small-scale setups.
Enquire Before Buying: https://www.alliedmarketresearch.com/purchase-enquiry/860
David Correa
Allied Market Research
+ 1800-792-5285
email us here
Visit us on social media:
LinkedIn
Facebook
YouTube
X
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
